Synchronous and bilateral spike-and-wave discharges accompany nonconvulsive behavioral and cognitive arrest during seizures associated with absence epilepsy.
INTRODUCTION
Absence seizures are characterized by periods of behavioral arrest, accompanied by glassy staring with loss of cognitive function, often without overt convulsions (McCormick and Contreras, 2001) . These generalized seizures include a brief loss of consciousness typically lasting 2-15 s with corresponding bilateral, synchronous ~3 Hz electrographic spike-and-wave discharges (SWDs) (Panayiotopoulos et al., 2008) . The generalized nature of absences, however, should not be rigidly interpreted to mean that there is no specific focus or generating region. SWD initiation has been localized to the perioral region of the somatosensory cortex in multiple animal models of absence epilepsy (Meeren et al., 2002; Meeren et al., 2005; van Luijtelaar & Sitnikova, 2006; van Luijtelaar et al., 2006; van Luijtelaar et al., 2011; L'uttjohann & van Luijtelaar, 2012; Pinault, 2003; Polack et al., 2007; Bazyan & van Luijtelaar, 2013) and local injection of different pharmaceutical agents into this area suppresses absence seizures in multiple SWD-expressing animal models (Manning et al., 2004; Chen et al., 2011; Bazyan & van Luijtelaar, 2013) . A "cortical focus theory" for absence seizures has been proposed and many absence animal models support this conclusion (Meeren et al., 2005; Steriade and Contreras, 1998; Sitnikova and van Luijtelaar, 2004; van Luijtelaar and Sitnikova, 2006; Polack et al., 2007) .
The γ2R43Q mutation, an arginine-to-glutamine substitution at position 43 of the GABA A receptor γ2 subunit, confers absence epilepsy and febrile seizures in humans (Wallace et al., 2001) . Compared to unaffected family members, patients harboring the γ2R43Q mutation display increased intracortical excitability, decreased intracortical inhibition, and increased cortical facilitation (Fedi et al., 2008) . Similarly, γ2R43Q knock-in (RQ) mice display absence seizures, generalized SWDs (~ 6 Hz), and increased cortical excitability (Tan et al., 2007; Mangan et al., 2013) . Results from several labs conclude that the γ2R43Q mutation alters the membrane trafficking of several GABA A receptor subunits to the cell surface (Kang & Macdonald, 2004; Sancar & Czajkowski, 2004; Hales et al., 2005; Eugene et al., 2007; Mangan et al., 2013) , including the α5 (Eugene et al., 2007) and δ (Mangan et al., 2013) subunits in cortex and thalamus, respectively. The altered trafficking of these specific subunits results in the loss of GABAergic tonic currents in principal neurons of the thalamocortical loop, leading to increased cortical excitability and decreased thalamic bursting behaviors (Mangan et al., 2013) .
Recently a link has been established between tonic inhibition and absenceassociated SWD generation, though this link is currently isolated to, and believed to be 'required' in, thalamic relay neurons (Fariello & Golden, 1987; Crunelli et al., 2011; Errington et al., 2011) . Evidence of this link includes findings that the increase of GABAergic tonic currents in thalamic relay neurons is sufficient to produce SWDs in wild-type rats, and multiple rodent models of absence epilepsy (GAERS, stargazer, lethargic, tottering) express increases in thalamic inhibitory tonic currents (Fariello & Golden, 1987; Crunelli et al., 2011; Errington et al., 2011) . The present study, however, demonstrates that this link must be expanded to include tonic inhibition in cortical neurons. Using continuous video-EEG monitoring and selective pharmacological manipulation of cortical tonic inhibition, we show that decreasing cortical inhibitory tonic currents is also 'sufficient' to produce SWDs in wild-type (RR) mice, and that rescuing the lost cortical tonic currents in RQ mice suppresses SWD expression.
RESULTS

RQ mice express SWDs and absence epilepsy.
The γ2R43Q mutation confers absence seizures and generalized EEG SWDs in humans 3 and knock-in (RQ) mice (Tan et al, 2007) . Figure 1 illustrates bilateral, synchronous (~6 Hz) SWDs in a RQ mice using continuous EEG and electromyogram (EMG) recordings. Quantification was done off-line after recordings were completed. A SWD 'bout' was classified as two or more individual SWD events occurring <30 seconds apart. SWDs were assessed for individual event duration, inter-bout-intervals (IBI), events per bout, and bout duration. EEG and EMG recordings from one RQ mouse during a SWD bout are presented ( Fig. 1A & 1B) , along with quantified SWD assessment for three different RQ mice (Fig. 1C ). All RQ mice assessed with EEG and EMG monitoring presented synchronized SWDs across all EEG leads with coincident cessation of EMG activity. No SWDs were observed in naïve wild-type (RR) mice. All values for all groups and conditions and measures are presented in Table 1 .
Blocking cortical tonic inhibition produces SWDs in wild-type mice.
It has been demonstrated that a positive correlation between SWDs and thalamic inhibitory tonic currents exists (Cope et al., 2009 ), leading to the conclusion that enhanced GABAergic tonic inhibition is "necessary and sufficient" condition to cause typical absence epilepsy Errington et al., 2011) . In sharp contrast, here we demonstrate that altering thalamic tonic inhibition is not necessary for SWD generation, and furthermore, blockade of cortical tonic inhibition is sufficient to produce SWDs (Fig. 2 ). Previously we reported that inhibitory tonic currents in somatosensory cortical layer II/III principal neurons are generated by α5 subunit-containing GABA A receptors and that this current is blocked by the α5 subunit-selective inverse agonist L655,708 (L655) (Mangan et al., 2013) . Intraperitoneal (i.p.) administration of L655, at a concentration (2 mg/kg) known to bind the majority of α5 subunit-containing receptors (Atack et al., 2006) , produced SWDs (~6 Hz) in RR mice (RRL6) that are electrographically similar to SWDs seen in RQ mice ( Fig. 2A & 2B ). However, L655
induced SWDs (L6-SWDs) display fewer events per bout (p<0.001) and shortened bout durations (p<0.001) compared to RQ, while individual L6-SWD event duration was longer (p<0.001). Also noteworthy is the appearance of SWDs 3 days after the last L655 injection ( Fig. 2D , hour 1 vehicle), suggesting lingering plasticity following initial insult and SWD induction.
GABA A receptor δ subunit-selective agonists rescue tonic inhibition in RQ cortical principal neurons.
Although RQ principal cortical neurons lack inhibitory tonic currents (Mangan et al., 2013) , these neurons also display an inhibitory conductance in response to selective δ subunit-associated GABA A receptor agonists (1 µM THIP (Cope et al., 2005; Adkins et al., 2001; Mangan et al., 2013) , 30 nM allopregnanolone (ALLO) (Fodor et al., 2005; Rajasekaran et al., 2010; Mangan et al., 2013) . This finding is consistent with the presence of latent δ subunit-containing GABA A receptors in RQ cortical neurons and suggests that the lost tonic inhibition in these neurons can be rescued. We used wholecell patch-clamp recordings to titrate a concentration of selective δ subunit-containing GABA A receptor agonists that rescued wild-type tonic inhibition levels in RQ cortical neurons. We found that a low concentration (10 nM) of Ganaxolone (GANX) (Fig. 3B ), a synthetic neuroactive steroid related to ALLO (Citraro et al., 2006) , activates a latent inhibitory conductance in RQ cortical neurons equal to the inhibitory tonic current observed in RR cortical neurons.
Rescuing cortical tonic inhibition attenuates SWDs in RQ mice.
Low doses of selective δ subunit-containing GABA A receptor agonists rescue tonic inhibition in RQ principal cortical neurons ( Fig. 3B ). Using video-EEG monitoring, we investigated if treatment with these δ subunit-selective GABA A receptor agonists (GANX or THIP) could ameliorate the SWDs observed in RQ mice.
RQ mice were i.p. injected twice a day with GANX or THIP for 4 out of 7 days (for drug schedule see Fig. 4A ). Multiple concentrations of GANX (2 and 5 mg/kg) and THIP (0.5 and 1.5 mg/kg) were tested for their ability to suppress SWD expression. Only the lowest concentration (2 mg/kg) of GANX was significantly (p<0.05) effective in decreasing RQ-SWD expression ( Fig. 4B) . This low dose of GANX treatment also decreased bout duration (p<0.05) and event duration (p<0.001), but did not affect the number of SWDs per bout. The selective efficacy of the low GANX dose (2 mg/kg), which is half the ED 50 dose that protects against partial seizures (Gasior et al., 1999; Kaminski et al., 2004) , suggests that the mechanism that diminishes SWDs in RQ mice involves activation of latent δ subunit-containing GABA A receptors in cortical neurons.
DISCUSSION
The major findings from this study are that the loss (RQ) ( suppresses SWD expression ( Fig. 4 ). These findings are consistent with the conclusion that the amount of cortical tonic inhibition regulates SWD expression. Thus, considering previous findings along with our research suggests the causal link between absence epilepsy and inhibitory tonic currents is at least bidirectional: increased thalamic tonic inhibition (Cope et al., 2009) or decreased cortical tonic inhibition; both can lead to epileptiform activity.
The link between absence seizures and increased δ subunit-associated GABA A receptor activation in thalamic relay neurons is well established (Fariello & Golden, 1987; Crunelli et al., 2011; Errington et al., 2011) . The current hypothesis from this evidence is that persistent hyperpolarization of thalamic relay neurons (Cope et al., 2005 (Cope et al., , 2009 ) makes these neurons more susceptible to rhythmic bursting and insensitive to sensory input, which is considered to be a necessary condition for SWD generation Errington et al., 2011) . Consistent with this hypothesis, ethosuximide and valproic acid, two different T-type Ca 2+ channel blockers, decrease thalamic relay bursting and are currently the main treatment options for absence epilepsy.
However, the efficacy of either drug for this condition is at only ~55% (Glauser et al., 2010) . The evidence presented in this study suggests a second classification for absence seizure generation that is separate from altered thalamic activity, and could apply to at least a portion of the remaining ~45% of patients that are currently not treatable by the main treatment options.
In vitro examination of thalamic relay bursting behaviors in thalamocortical mouse brain slices detected a decrease or no change in bursting behaviors compared to control for RQ and L655-treated (RR) brain slices, respectively (Mangan et al., 2013) .
Additionally, RQ thalamic relay neurons display no inhibitory tonic currents (Mangan et al., 2013) . These results suggest that neither increased thalamic tonic inhibition nor the resulting increased susceptibility to rhythmic bursting is essential for SWD generation.
Furthermore, the SWDs expressed endogenously in WAG/Rij rats is quenched by local application of ganaxolone or allopregnanolone into somatosensory cortex, a treatment that would not directly affect thalamic relay neuron tonic inhibitory levels or bursting susceptibility (Citraro et al., 2006) . It is likely, however, that this treatment to WAG/Rij rats increased cortical tonic inhibitory levels, further suggesting that cortical inhibitory levels regulate SWD expression.
Our findings suggest that SWDs are linked to general cortical tonic inhibition levels and not to a specific tonic current-associated GABA A receptor subtype (α5 or δ).
Rescuing RQ cortical tonic inhibition via activation of δ-subunit-associated GABA A receptors with GANX, and the subsequent decrease in SWD expression (Fig 4) , indicates that SWD expression can be regulated by δ-subunit-associated tonic inhibition.
Conversely, the selective decrease/block of α5 subunit-associated inhibition (RR-L655), which results in SWD expression ( Fig. 2) , indicates that SWD expression can also be regulated by α5 subunit-associated tonic inhibition.
We found evidence of long-lasting aberrant thalamocortical function after inducing SWDs with L655 in wild-type mice. Mice that were injected twice a day for 2 consecutive days with L655 still displayed SWDs 3 days after the last injection ( Fig. 2D: vehicle, Hour 1, p<0.05). Given that the half-life of L655 in multiple animal models (rat, dog, rhesus monkey) is 0.3 -0.5 hours (Atack et al., 2009) , this result suggests lingering pro-epileptic plasticity of the thalamocortical circuit follows initial seizure insult. Similar pro-seizure susceptibility has been noted in other epilepsy-induced animal models (Yu et al., 2013; Peng et al., 2004; Houser & Esclapez, 2003) . Getting the earliest possible therapeutic intervention should be a high priority for individuals suffering from absence epilepsy.
Optimal Tonic Inhibition
GANX is the only neurosteroid evaluated as an anti-epileptic drug in humans (Monaghan et al., 1999; Nohria et al., 2010; Reddy and Rogawski 2012) . It has been clinically studied for the treatment of infantile spasms (Kerrigan et al., 2000) and shown to be effective, with minimal side effects (sedation), as a treatment for catamenial epilepsy (Reddy and Rogawski, 2009 ) and partial seizures (Laxer et al., 2000) in adults.
However, investigation of GANX in animal models of absence epilepsy (PTZ, GHB) uncovered that it exacerbates absence seizures and can even produce SWDs in wild-type rats when administered at ≥ 20 mg/kg (Snead III; 1998) . Thus, how can we suggest GANX can be effective as a treatment for absence epilepsy?
Neurosteroids activate GABA A receptors directly but are known to produce the largest magnitude effects at δ subunit-containing GABA A receptors and are selective for this receptor subtype only at lower concentrations (Reddy and Rogawski, 2009 ). Our current results suggest a dichotomy of effects for neurosteroids in the CNS: higher concentrations result in general sedation and SWD generation or exacerbation, and lower levels produce normal functionality and ameliorate SWDs in RQ mice. Similarly, we suggest a concentration dependent consideration of thalamocortical tonic inhibition in regards to SWDs and absence seizure generation.
Evaluation of polygenic (GAERS, stargazer, lethargic) and pharmaco-induced (GHB, PTZ) rodent models of absence epilepsy provide substantial evidence that too much thalamic tonic inhibition triggers SWDs (Cope et al., 2009; Snead III, 1998) .
Equally, here we present a novel absence animal model (L655) and treatment for a known absence animal model (RQ) that indicate reduced cortical tonic inhibition results in SWDs. These findings suggest that an optimum level of tonic inhibition in the thalamocortical circuit is required for normal functioning and that deviation from this optimum in either direction results in aberrant thalamocortical function, SWDs and absence seizures. 
METHODS
EEG implantation and monitoring of SWDs
The present study used male and female wild-type Harlan C57BL/6J-OlaHsd and γ2R43Q knock-in mice bred into a background of Harlan C57BL/6J-OlaHsd mice.
Behavioral and electrographic markers of absence epilepsy in these animals were confirmed by video-EEG monitoring. Surgery and electrode implantation are described in Nelson et al. (2013) . Briefly, P24 mice were implanted, under isoflurane anesthesia (1%-2% in 100% O 2 ), for chronic EEG recordings with gold plated miniature screw electrodes over the right and left frontal and parietal cortices, and one over the cerebellum as reference. Two vinyl-coated braided stainless steel wire electrodes were placed in the nuchal muscle for electromyogram (EMG) recording of muscle activity. All electrodes were gathered into a flexible cable and connected to the Multichannel Neurophysiology
Recording system (Tucker-Davis Technologies, TDT, Alachua, FL, USA). EEG and EMG signals were collected continuously at a sampling rate of 256 Hz (digitally filtered between 0.1 and 100 Hz). Continuous EEG recordings with occasional video monitoring were made and SWDs were scored off-line. Animals were given a 3-day recover period after surgery before SWD scoring began. A SWD event was defined as a brief (~2 seconds long) ~6 Hz signal synchronized across all EEG leads, with a corresponding lack of signal in the EMG lead. Only SWD events that occurred >2 min from slow-wave-sleep periods were used for quantification. SWD event durations were measured from the first synchronized positive peak signal to the last synchronized positive peak within an event.
SWD "bouts" were defined as groups of SWD events separated from other events by <30 seconds. Interbout-intervals were defined as the time between the beginnings of consecutive bouts.
All animal procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals and facilities were reviewed and approved by the IACUC of the University of Wisconsin-Madison, and were inspected and accredited by AAALAC.
Drugs and Injection Schedule
L655,708 (L9787), GANX (G7795) and THIP (T101) were all obtained from Sigma (St. Louis, MO). L655 and GANX were dissolved in a 30% DMSO-saline solution (v/v), while THIP was dissolved in 100% saline. Mice were intraperitoneally (i.p.)
injected with 2 mg/kg doses of L655, 2 and 5 mg/kg doses of GANX, or 0.5 and 1.5 mg/kg doses of THIP. 160 uL of solution was injected for each drug. L655 was administered to RR mice 2 and 4 hours after lights out (Fig 2) for 2 consecutive days beginning 5 days after surgery. These mice were not injected for the subsequent 2 days, but were given vehicle injections on day 9. Ganxolone or THIP injections were administered to RQ mice 1 and 4 hours after lights out (Fig. 4) . Drug injections for RQ mice began on day 5 after surgery and consisted of 2 injections of one drug and dose, with a different drug and dose for days 6, 10, and 11. No injections were given to RQ mice on days 7-9.
Whole-cell Patch Clamp Experiments
Horizontal slices (400 µm and placed in an incubation chamber containing standard artificial cerebrospinal fluid (aCSF) (in mM): 125 NaCl, 25 NaHCO 3 , 2.5 KCl, 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 , 25 D-Glucose, at room temperature for 1 hour before being used for recordings. Whole cell patch-clamp recordings were made from somatosensory cortical layer II/III pyramidal cells, visualized using an upright differential interference contrast microscope (Axioskop FS2, Zeiss; Oberkochen, Germany). Patch pipettes were pulled from thin-walled borosilicate glass (World Precision Instruments; Sarasota, FL) with a resistance of 3-5 MΩ when filled with intracellular solution containing (in mM): 140 KCl, 10 EGTA, 10 HEPES, 20 phosphocreatine, 2 Mg 2 ATP, 0.3 NaGTP (pH 7.3, 310 mOsm). Voltageclamp (-60 mV) recordings were made in a submerged chamber at room temperature using a MultiClamp 700B amplifier (Axon Instruments; Foster City, CA), filtered at 4 kHz and digitized at 10 kHz using a Digidata 1322A analog-digital interface (Axon Instruments). Data were acquired to a Macintosh G4 (Apple Computer; Cupertino, CA)
using Axograph X v1.1.4 (Molecular Devices; Sunnyvale, CA).
Data segments (30 s) just prior to and 90 s after drug administration were analyzed to quantify inhibitory tonic currents. All-point amplitude histograms were computed for each segment, and fit with a Gaussian function only to the outward current portions relative to the peak in order to omit components arising from inward phasic mIPSCs 39 . Tonic current was calculated as the difference between the fitted Gaussian means before and after (100 or 1 µM) THIP, (30 nM) ALLO, or (10 nM) GANX administration. Current density (pA/pF) was calculated by dividing the current by cell capacitance. Bicuculline (100 µM) was added at the conclusion of at least one experiment for each drug tested to verify full current block and, thus, only GABAergic contribution.
Statistics
The Kruskal-Wallis test of medians was used to compare multiple groups with a Dunn's post-hoc evaluation. Tonic current amplitude and density data were normally distributed, thus an ANOVA was used to compare multiple groups with a Bonferroni post-hoc evaluation. Matlab and Prism software was used.
